Perelman School of Medicine

The next frontier of precision medicine: Parkinson’s disease

The Molecular Integration in Neurological Diagnosis (MIND) Initiative is working to understand the nature of Parkinson's disease with molecular-level accuracy, so doctors can treat the root cause.

Seven Penn researchers receive NIH Director Awards

Seven researchers from the Perelman School of Medicine, School of Veterinary Medicine, and School of Engineering and Applied Science are to receive National Institutes of Health Director Awards, highly competitive grants to support innovative biomedical research.

To reduce concussions in football, change kickoffs

Research findings support an experimental rule in football that reduced concussions by moving the kickoff line from the 35- to 40-yard line and the touchback line from the 25- to 20-yard line.

Discovering a single cell that leads to relapse

Research from the Abramson Cancer Center identified a single leukemic cell, engineered for CAR T therapy, that caused a deadly recurrence of pediatric B-cell acute lymphoblastic leukemia.

DNA vaccine leads to immune responses in HPV-related head and neck cancer

Researchers from the Abramson Cancer Center find immunotherapy approach can help T cells infiltrate tumors.

What happens to the brain after a traumatic injury?

Two undergrads interning with Penn Medicine’s Ramon Diaz-Arrastia spent the summer looking for biomarkers in the blood of TBI patients, and studying whether the generic form of Viagra might help promote recovery after such an injury.

Teachers become students to become better teachers at GRASP Lab’s RET program

The Research Experiences for Teachers (RET) program run by the GRASP Lab in the School of Engineering and Applied Science is part of a larger National Science Foundation effort to get students interested in science and engineering at an early age. This summer, one cohort of students worked with robots in the Rehabilitation Robotics Lab at the Perelman School of Medicine.

Flu vaccination rates in clinics drop as day progresses, but ‘nudges’ give them a boost

A new study shows that nudges prompting staff to create templates for vaccine orders increases flu vaccination rates.

Targeting a viral vulnerability to treat disease

Robert Ricciardi company ViRAZE utilizes interdisciplinary approaches to drug discovery. Its first target is molluscum contagiosum, a disease that targets children and immune-compromised adults with no current FDA-approved therapy.

Finding patterns in a class of neurological disorders

Research from Penn Engineering and the Perelman School of Medicine has found that the shared pattern is misfolded in Fragile X Syndrome, a member of the class of disorders that also includes ALS and Huntington’s disease

Filters